Tysabri every eight weeks may cut PML risk
Tysabri every eight weeks may cut PML risk
Preliminary findings from an ongoing study of multiple sclerosis patients suggest the dosing interval for Tysabri can be as much as doubled from the label-recommended standard without sacrificing efficacy, and with potentially less risk of progressive multifocal leukoencephalopathy (PML) -- even among patients with more than average PML risk, researchers claim... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2543 Views
-
Last post by NHE
-
- 0 Replies
- 132 Views
-
Last post by NHE
-
- 6 Replies
- 7380 Views
-
Last post by ElliotB
-
- 0 Replies
- 3768 Views
-
Last post by NHE
-
- 0 Replies
- 1419 Views
-
Last post by NHE
-
- 0 Replies
- 146 Views
-
Last post by NHE
-
- 0 Replies
- 3466 Views
-
Last post by NHE
-
- 11 Replies
- 3531 Views
-
Last post by NHE
-
- 1 Replies
- 1148 Views
-
Last post by NHE